Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Operating Expenses | 1,628 | 1,646 | 3,136 | 4,185 | 5,814 |
| Operating Income | -1,628 | -1,646 | -3,136 | -4,185 | -5,814 |
| Interest Expense | 127 | 111 | 89 | 120 | 32 |
| Other Income | 1,081 | 1,430 | -2,548 | -4,047 | 27 |
| Pre-tax Income | -674 | -327 | -5,773 | -8,352 | -5,819 |
| Net Income Continuous | -674 | -327 | -5,773 | -8,352 | -5,819 |
| Net Income | $-674 | $-327 | $-5,773 | $-8,352 | $-5,819 |
| EPS Basic Total Ops | -0.86 | 0.00 | -7.39 | -11.00 | -7.00 |
| EPS Basic Continuous Ops | -0.86 | -0.42 | -7.39 | -10.82 | -7.44 |
| EPS Diluted Total Ops | -0.86 | 0.00 | -7.39 | -11.00 | -7.00 |
| EPS Diluted Continuous Ops | -0.86 | -0.42 | -7.39 | -10.82 | -7.44 |
| EBITDA(a) | $-1,128 | $-1,645 | $-3,135 | $-1,836 | $-3,197 |